2022
Dasiglucagon demonstrates reduced costs in the treatment of severe hypoglycemia in a budget impact model
Hinahara J, Weinzimer SA, Bromley ER, Goss TF, Kendall DM, Hammer M. Dasiglucagon demonstrates reduced costs in the treatment of severe hypoglycemia in a budget impact model. Journal Of Managed Care & Specialty Pharmacy 2022, 28: 10.18553/jmcp.2022.28.4.461. PMID: 35332789, PMCID: PMC10373001, DOI: 10.18553/jmcp.2022.28.4.461.Peer-Reviewed Original ResearchConceptsBudget impact modelHealth care resource utilizationSevere hypoglycemiaSH eventsGlucagon treatmentNasal glucagonUS commercial health planLower total health care costsSuccessful administrationTotal direct medical costsTotal health care costsPlasma glucose recoveryEmergency department visitsSevere hypoglycemic eventsInitial treatment successDirect medical costsCommercial health plansType 2 diabetesHealth care costsHealth economic modelEmergency medical servicesNative glucagonGlucagon analogsInjectable glucagonPrompt administrationReal‐World Diabetes Technology: What Do We Have? Who Are We Missing?
Messer LH, Weinzimer SA. Real‐World Diabetes Technology: What Do We Have? Who Are We Missing? Diabetes Technology & Therapeutics 2022, 24: s-159-s-172. PMID: 35475693, DOI: 10.1089/dia.2022.2510.Peer-Reviewed Original ResearchDiabetes Mellitus, Type 2Humans
2017
Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange
Agiostratidou G, Anhalt H, Ball D, Blonde L, Gourgari E, Harriman KN, Kowalski AJ, Madden P, McAuliffe-Fogarty AH, McElwee-Malloy M, Peters A, Raman S, Reifschneider K, Rubin K, Weinzimer SA. Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care 2017, 40: 1622-1630. PMID: 29162582, PMCID: PMC5864122, DOI: 10.2337/dc17-1624.Peer-Reviewed Original ResearchConceptsPatient-reported outcomesType 1 diabetesAmerican Diabetes AssociationPediatric Endocrine SocietyDiabetic ketoacidosisEndocrine SocietyClinical EndocrinologistsPriority outcomesDiabetes AssociationT1D ExchangeHarry B. Helmsley Charitable TrustDiabetes educatorsLong-term clinical impactType 1American AssociationType 2 diabetesSteering CommitteeLeona M.Helmsley Charitable TrustMeaningful outcome measuresType 1 diabetes outcomesAdvisory CommitteeInternational Consensus on Use of Continuous Glucose Monitoring
Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care 2017, 40: 1631-1640. PMID: 29162583, PMCID: PMC6467165, DOI: 10.2337/dc17-1600.Peer-Reviewed Original Research
2003
Body composition and metabolic factors in obese children and adolescents
Tershakovec AM, Kuppler KM, Zemel BS, Katz L, Weinzimer S, Harty MP, Stallings VA. Body composition and metabolic factors in obese children and adolescents. International Journal Of Obesity 2003, 27: 19-24. PMID: 12532149, DOI: 10.1038/sj.ijo.0802185.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentBody CompositionBody Mass IndexChildDiabetes ComplicationsDiabetes MellitusDiabetes Mellitus, Type 2FemaleHumansInsulin ResistanceMaleObesityConceptsVisceral abdominal fatSubcutaneous abdominal fatLeptin levelsInsulin levelsFat massObese childrenAbdominal fatBody compositionHOMA-IRInsulin resistanceMetabolic factorsTotal body fat massDual-energy X-ray absorptiometryEnergy X-ray absorptiometryHigher HOMA-IRHomeostasis model assessmentNon-obese childrenHigher insulin levelsBody fat massTotal body fatGroup differencesRegional fat distributionCross-sectional assessmentX-ray absorptiometryLow glucose levels